Publication | Closed Access

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

As04-adjuvanted VaccineGynecologyOncogenic Hpv TypesCancer-associated VirusCervical Cancer PreventionHuman Papillomavirus VaccinesPublic HealthVaccine SafetyCervical HealthEpidemiologyVaccinationCervical Cancer ManagementCervical Cancer ScreeningCervical CancerVaccine EfficacyYoung WomenMedicineVaccine ResearchPrecancerous Lesions